Keyphrases
Intravenous Ketamine
100%
Motor Impulsivity
100%
Ampakine
100%
Ketamine
66%
Impulsivity
50%
AMPA Receptor (AMPAR)
33%
Neuropsychiatric Disorders
33%
Impulse Control
33%
Schizophrenia
16%
Pharmacological Approaches
16%
N-methyl-D-aspartate Receptor (NMDAR)
16%
Receptor Signaling
16%
Glutamate
16%
FDA-approved Drugs
16%
Amino
16%
Synaptic
16%
Sprague-Dawley Rats
16%
Non-competitive
16%
Repeated Treatment
16%
Substance Use Disorder
16%
Treatment-resistant Depression
16%
Synaptic Remodeling
16%
Glutamate Neurotransmission
16%
Behavioral Dimension
16%
Attention Deficit Hyperactivity Disorder
16%
Methyl
16%
Psychiatry
16%
N-methyl-D-aspartate Receptor Antagonist
16%
Single Treatment
16%
Outbred
16%
Ionotropic Receptor
16%
Serial Reaction Time Task
16%
Endophenotype
16%
Positive Allosteric Modulation
16%
Neuroscience
Impulsivity
100%
Ketamine
100%
Ampakine
100%
Receptor
44%
Glutamic Acid
22%
NMDA Receptor Antagonist
11%
Synaptic Transmission
11%
Aspartic Acid
11%
Attention Deficit Hyperactivity Disorder
11%
Psychiatry
11%
Treatment-Resistant Depression
11%
Ionotropic Receptor
11%
Ionotropic Glutamate Receptor
11%
Endophenotype
11%